Tolbutamide and Inability to speak - from FDA reports


Inability to speak is reported only by a few people who take Tolbutamide. We study 585 people who have side effects while taking Tolbutamide from FDA. Among them, 5 have Inability to speak. Find out below who they are, when they have Inability to speak and more.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Aug, 20, 2018

585 people reported to have side effects when taking Tolbutamide.
Among them, 5 people (0.85%) have Inability to speak


Number of reports submitted per year:

Could Tolbutamide cause Inability to speak?

Gender of people who have Inability to speak when taking Tolbutamide *:

  • female: 20 %
  • male: 80 %

Age of people who have Inability to speak when taking Tolbutamide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  1. Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 20.00%
  2. Hypoaesthesia (reduced sense of touch or sensation): 1 person, 20.00%
  3. High Blood Pressure: 1 person, 20.00%
  4. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 20.00%
Check whether a drug or a condition causes Inability to speak

Top co-used drugs for these people *:

  1. Symbicort: 1 person, 20.00%
  2. Sunitinib Malate: 1 person, 20.00%
  3. Simvastatin: 1 person, 20.00%
  4. Omeprazole: 1 person, 20.00%
  5. Norvasc: 1 person, 20.00%
  6. Metformin Hydrochloride: 1 person, 20.00%
  7. Lyrica: 1 person, 20.00%
  8. Levothyroxine Sodium: 1 person, 20.00%
  9. Lansoprazole: 1 person, 20.00%
  10. Humira: 1 person, 20.00%
Subscribe to monitor Inability to speak in Tolbutamide

Top other side effects for these people *:

  1. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 40.00%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 20.00%
  3. Stress And Anxiety: 1 person, 20.00%
  4. Blood Pressure Systolic Increased: 1 person, 20.00%
  5. Cerebral Haemorrhage (bleeding within the brain): 1 person, 20.00%
  6. Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 20.00%
  7. Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 1 person, 20.00%
  8. Communication Disorder (speech and language disorder): 1 person, 20.00%
  9. Confusional State: 1 person, 20.00%
  10. Depressed Mood: 1 person, 20.00%
Click here to get more results

* Approximation only. Some reports may have incomplete information.

Are you new to Tolbutamide or have questions?

Volunteer or get paid to help people with your care experience



Related studies

Tolbutamide

Tolbutamide has active ingredients of tolbutamide. It is often used in diabetes. (latest outcomes from Tolbutamide 588 users)

Inability to speak

Inability to speak has been reported by people with multiple sclerosis, high blood pressure, depression, pain, rheumatoid arthritis (latest reports from 47,726 Inability to speak patients).


Drugs that are associated with Inability to speak
Inability to speak (1,542 drugs)
Could your condition cause Inability to speak
Inability to speak (2,671 conditions)
Tolbutamide side effects
Browse all side effects of Tolbutamide
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Tolbutamide and have Inability to speak


You are not alone. Join our personalized support groups:


You may be interested in these posts

More posts for: Tolbutamide, Inability to speak

Recent updates

General studies

You could also:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.